Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Acute Leukemia
August 14, 2018
Relapsed or Refractory Adult Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
August 14, 2018
Relapsed Acute Myeloid Leukemia
Dr. C H Weaver MD
August 14, 2018
Treatment of Childhood Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
December 22, 2017
Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS
Dr. C H Weaver MD
September 1, 2017
FDA Approves First Gene Therapy
Dr. C H Weaver MD
August 22, 2017
Besponsa for B-cell Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
May 10, 2017
FDA Approves Rydapt for Treatment of Acute Myeloid Leukemia
Dr. C H Weaver MD
November 14, 2016
Childhood Acute Lymphoblastic Leukemia: Screening/Prevention
Dr. C H Weaver MD
September 26, 2016
Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
August 9, 2016
Pracinostat Receives Designation from FDA for Treatment with Newly Diagnosed AML
Dr. C H Weaver MD
July 4, 2016
GlycoMimetics Receives FDA Designation for Treatment of Acute Myeloid Leukemia
Dr. C H Weaver MD
March 30, 2016
Vyxeos™ Improves Survival for Elderly in AML
Dr. C H Weaver MD
Previous Page
1
2
3
4
5
…
9
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
